BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17598916)

  • 1. New chemically induced skin tumour susceptibility loci identified in a mouse backcross between FVB and dominant resistant PWK.
    Fujiwara K; Igarashi J; Irahara N; Kimura M; Nagase H
    BMC Genet; 2007 Jun; 8():39. PubMed ID: 17598916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent genetic control of early and late stages of chemically induced skin tumors in a cross of a Japanese wild-derived inbred mouse strain, MSM/Ms.
    Okumura K; Sato M; Saito M; Miura I; Wakana S; Mao JH; Miyasaka Y; Kominami R; Wakabayashi Y
    Carcinogenesis; 2012 Nov; 33(11):2260-8. PubMed ID: 22843548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New outbred colony derived from Mus musculus castaneus to identify skin tumor susceptibility loci.
    Fujiwara K; Wie B; Elliott R; Nagase H
    Mol Carcinog; 2010 Jul; 49(7):653-61. PubMed ID: 20564342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of new skin tumor susceptibility loci by a phenotype-driven congenic approach.
    Fujiwara K; Inagaki Y; Soma M; Ozaki T; Nagase H
    Oncol Lett; 2018 Nov; 16(5):6670-6676. PubMed ID: 30405807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allele-specific Hras mutations and genetic alterations at tumor susceptibility loci in skin carcinomas from interspecific hybrid mice.
    Nagase H; Mao JH; Balmain A
    Cancer Res; 2003 Aug; 63(16):4849-53. PubMed ID: 12941805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel genetic loci contributing to 12-O-tetradecanoylphorbol-13-acetate skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice.
    Angel JM; Caballero M; DiGiovanni J
    Cancer Res; 2003 Jun; 63(11):2747-51. PubMed ID: 12782578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Panx3 links body mass index and tumorigenesis in a genetically heterogeneous mouse model of carcinogen-induced cancer.
    Halliwill KD; Quigley DA; Kang HC; Del Rosario R; Ginzinger D; Balmain A
    Genome Med; 2016 Aug; 8(1):83. PubMed ID: 27506198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct genetic loci control development of benign and malignant skin tumours in mice.
    Nagase H; Bryson S; Cordell H; Kemp CJ; Fee F; Balmain A
    Nat Genet; 1995 Aug; 10(4):424-9. PubMed ID: 7670492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Stmm3 locus conferring resistance to late-stage chemically induced skin papillomas on mouse chromosome 4 by congenic mapping and allele-specific alteration analysis.
    Saito M; Okumura K; Miura I; Wakana S; Kominami R; Wakabayashi Y
    Exp Anim; 2014; 63(3):339-48. PubMed ID: 25077764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility to phorbol ester skin tumor promotion in (C57BL/6 x DBA/2) F1 mice is inherited as an incomplete dominant trait: evidence for multi-locus involvement.
    Naito M; Chenicek KJ; Naito Y; DiGiovanni J
    Carcinogenesis; 1988 Apr; 9(4):639-45. PubMed ID: 3128409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epistatic interactions between skin tumor modifier loci in interspecific (spretus/musculus) backcross mice.
    Nagase H; Mao JH; de Koning JP; Minami T; Balmain A
    Cancer Res; 2001 Feb; 61(4):1305-8. PubMed ID: 11245425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic analyses of mouse skin tumor progression susceptibility using SENCAR inbred derived strains.
    Stern MC; Benavides F; LaCava M; Conti CJ
    Mol Carcinog; 2002 Sep; 35(1):13-20. PubMed ID: 12203363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
    Owens DM; Spalding JW; Tennant RW; Smart RC
    Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
    Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
    Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haploinsufficiency of the cdc2l gene contributes to skin cancer development in mice.
    Chandramouli A; Shi J; Feng Y; Holubec H; Shanas RM; Bhattacharyya AK; Zheng W; Nelson MA
    Carcinogenesis; 2007 Sep; 28(9):2028-35. PubMed ID: 17389615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of chemical carcinogenesis--II. Papilloma induction and malignant conversion in susceptible (Car-s) and resistant (Car-R) lines of mice produced by bidirectional selective breeding and in their (Car-S X Car-R) F1 hybrids.
    Pioli C; Saran A; Mouton D; Troiani C; Doria G; Covelli V; Neveu T; Biozzi G
    Carcinogenesis; 1994 Nov; 15(11):2629-35. PubMed ID: 7955117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenic mapping and allele-specific alteration analysis of Stmm1 locus conferring resistance to early-stage chemically induced skin papillomas.
    Okumura K; Saito M; Isogai E; Miura I; Wakana S; Kominami R; Wakabayashi Y
    PLoS One; 2014; 9(5):e97201. PubMed ID: 24844776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin.
    Ridd K; Zhang SD; Edwards RE; Davies R; Greaves P; Wolfreys A; Smith AG; Gant TW
    Carcinogenesis; 2006 Aug; 27(8):1556-66. PubMed ID: 16537558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metallothionein deficiency enhances skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate in metallothionein-null mice.
    Suzuki JS; Nishimura N; Zhang B; Nakatsuru Y; Kobayashi S; Satoh M; Tohyama C
    Carcinogenesis; 2003 Jun; 24(6):1123-32. PubMed ID: 12807749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelotype analysis of chemically induced squamous cell carcinomas in F(1) hybrids of two inbred mouse strains with different susceptibility to tumor progression.
    Stern MC; Benavides F; Klingelberger EA; Conti CJ
    Carcinogenesis; 2000 Jul; 21(7):1297-301. PubMed ID: 10874006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.